Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-1593-2025

MEDLINE INDUSTRIES, LP - Northfield recalls Medline Convenience kits used for various procedures: 1) LINE INSERTION PACK

MEDLINE INDUSTRIES, LP - NorthfieldNorthfield, IL, United StatesReported Apr 23, 2025 · 1 year ago
Legal News Analyst ·

Reason for recall

There is a potential for open/weak seals on purchased breather pouches used for packaging of select sterile convenience kits.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Medline Convenience kits used for various procedures: 1) LINE INSERTION PACK, Model Number: DYNJ44949C; 2) PICC LINE INSERTION BJC-LF, Model Number: DYNJ41682C; 3) SUPERFICIAL VENOUS PROCEDURE, Model Number: DYNJ81267A; 4) ILR INSERTION-REMOVAL PACK, Model Number: DYNJ82437A; 5) C LINE INSERTION CDS, Model Number: CDS980379J; 6) BSHR PICC LINE-LF, Model Number: DYNJ24529M; 7) ENSEMBLE POWER PICC-HEJ-LF, Model Number: DYNJ65827; 8) PICC LINE PACK, Model Number: DYNJ55170F; 9) LINE INSERTION PACK, Model Number: DYNJ44949C; 10) RFA PACK, Model Number: DYNJ67899A; 11) KIT CENTRAL LINE INSERTION-LF, Model Number: PHS902533005; 12) INFANT LUMBAR PUNCTURE TRAY, Model Number: DYNDH1904; 13) PICC PACK-LF, Model Number: DYNJ55356A; 14) GENERAL TRAY, Model Number: DYNJ15652M; 15) CVR ENDOVENOUS PACK, Model Number: DYNJ80643; 16) LINE INSERTION TRAY, Model Number: DYNJ20803D

Lot / code information

UDI
10193489769227(each), 40193489769228(case)
Lot #
24IBS279; 2) DYNJ41682C
UDI
10198459085512(each), 40198459085513(case)
Lot #
24JBM452; 3) DYNJ81267A
UDI
10195327352356(each), 40195327352357(case)
Lot #
24JBO094; 4) DYNJ82437A
UDI
10198459111006(each), 40198459111007(case)
Lot #
24JBT077; 5) CDS980379J
UDI
10195327054908(each), 40195327054909(case)
Lot #
24JBT886; 6) DYNJ24529M
Show 22 more code fields
UDI
10193489678284(each), 40193489678285(case)
Lot #
24JBT947; 7) DYNJ65827
UDI
10193489298499(each), 40193489298490(case)
Lot #
24JBW632; 8) DYNJ55170F
UDI
10195327614652(each), 40195327614653(case)
Lot #
24KBB128; 9) DYNJ44949C
UDI
10193489769227(each), 40193489769228(case)
Lot #
24KBB902; 10) DYNJ67899A
UDI
10198459071485(each), 40198459071486(case)
Lot #
24KBC476; 11) PHS902533005
UDI
10889942043927(each), 40889942043928(case)
Lot #
24KBD388; 12) DYNDH1904
UDI
10195327463779(each), 40195327463770(case)
Lot #
24KBD507; 13) DYNJ55356A
UDI
10193489646191(each), 40193489646192(case)
Lot #
24KBE301; 14) DYNJ15652M
UDI
10198459169410(each), 40198459169411(case)
Lot #
24KBE666; 15) DYNJ80643
UDI
10195327055790(each), 40195327055791(case)
Lot #
24KBH524; 16) DYNJ20803D
UDI
10889942553884(each), 40889942553885(case)
Lot #
24KBJ200

What the firm is doing

An IMMEDIATE ACTION REQUIRED MEDLINE DEVICE RECALL notification letter dated 3/3/25 was sent to customers. REQUIRED ACTION: 1.Immediately check your stock for the affected item number and the affected lot numbers which can be located within the recall portal. 2.Please use the link and the information below to complete your response form. Please list the quantity of affected product you have in inventory on the form. Even if you do not have any affected product in inventory, please complete and submit the response form. 3.Please destroy any affected inventory. Medline will issue credit for the product based upon the quantity and lot numbers identified on the submitted response form The login for completing the response form is: Website link: https://recalls.medline.com Recall Reference #: R-25-050-FG Recall Code: RECALL CODE 4.If you are a distributor, or have resold or transferred this product to another company or individual, you are required by FDA regulations to notify them of this recall communication. Please request that customers document and destroy any affected product, and include your customer s quantities on your response form. If you have any questions, contact the Recall Department at 866-359-1704 or recalls@medline.com.

DistributionShow details

Worldwide distribution - US Nationwide and the countries of Canada, Mexico, Panama, Virgin Islands.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls